Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Repligen and M.I.T. Sue ImClone Over Cancer Drug | 06-May-2004 | New York Times |
| Trials End Parents' Hopes for Autism Drug | 06-Jan-2004 | New York Times |
| Currency | US Dollars |
| Share Price | $ 4.37 |
| Change Today | $ -0.16 |
| % Change | -3.53 % |
| 52 Week High | $7.26 |
| 52 Week Low | $2.64 |
| Volume | 136,315 |
| Shares Issued | 30.85m |
| Market Cap | $134.80m |
| Beta | 0.20 |
| RiskGrade | 568 |
| Time | Volume / Share Price |
| 16:00 | 228 @ $4.37 |
| 15:59 | 100 @ $4.37 |
| 15:59 | 202 @ $4.37 |
| 15:59 | 100 @ $4.37 |
| 15:59 | 143 @ $4.37 |
You are here: research